A recurring confusion arises in diligence meetings, namely whether a granted patent or a patentability search means one can freely make and sell a product. It does not. Freedom to Operate is a separate legal question that focuses on third-party patent rights in the target market. In India, infringement turns on the scope of claims under Section 48 of the Patents Act. An FTO exercise maps your specific product or process against those claims to assess infringement risk and the need for design-around or licensing.
What exactly is FTO?
Freedom to Operate is the likelihood that making, using, selling, offering for sale, or importing your product in India will not infringe any in-force Indian patent claims. Section 48 sets out the patentee’s exclusive rights, which become the yardstick during infringement analysis. In practice, FTO work dissects active patent claims, pending claims that may soon grant, and the precise features of your product, then evaluates literal infringement and obvious equivalents.
Courts emphasise a claim-focused approach. In F. Hoffmann-La Roche v Cipla (Delhi High Court, 2015), the Division Bench analysed whether Cipla’s erlotinib product fell within Roche’s patent claims and held infringement, directing accounting of profits. The ratio that matters for FTO is simple: infringement turns on claim scope mapped to the product, not on overall therapeutic intent or brand names.
Why FTO matters beyond patentability?
A patentability or novelty search asks, can I get a patent. An FTO asks, can I launch without infringing. Indian courts have not hesitated to grant impactful interim and final relief where infringement is shown. In Merck Sharp & Dohme v Glenmark (Delhi High Court, 2015), the court granted injunctive relief in a DPP-4 inhibitor dispute, illustrating the commercial consequences when a marketed product is found to tread on another’s claims. The Supreme Court in Bajaj Auto v TVS Motor (2009) reiterated the principles for interim injunctions in patent cases, namely a strong prima facie case, balance of convenience, and irreparable harm, which in turn makes pre-launch risk assessment critical.
FTO also reduces deal friction. Investors, distributors, and licensees often condition term sheets on an FTO opinion. It signals preparedness, reveals licensing needs early, and avoids costly redesigns after tooling or regulatory submissions.
When do you need an FTO search?
Before design freeze and certainly before commercial launch.
Many teams run an initial screen at concept stage, then a full FTO just before locking specifications and supplier drawings. This sequencing keeps redesign options open if blocking claims are found.
Before India-specific manufacturing or import decisions.
Because FTO is jurisdictional, clearance in another country does not translate to India. Run India-specific checks on the IP India databases, namely Public Search, the E-Register for legal status, and Application Status for pendency.
When relying on regulatory exceptions.
Section 107A, the Bolar-type exception, permits acts reasonably related to obtaining regulatory approvals. The Delhi High Court in Bayer Corporation v Union of India (2019) clarified that even limited export for generating regulatory data may fall within Section 107A, subject to safeguards. This exception does not extend to commercial supply. Hence, pre-launch FTO remains necessary despite development or bio-equivalence work being shielded.
How an FTO is different from a patentability search
Feature | Patentability / Prior-art Search | Freedom to Operate Search |
Core question | Can I obtain a patent | Can I launch without infringing |
Focus | Prior art worldwide, novelty and inventive step | In-force and pending patents in target market, claim scope |
Documents screened | Publications and granted patents as prior art, often broad | Granted patents, pending applications and families, legal status, claim history |
Output | Patentability assessment and drafting pointers | Claim charts, risk rating, design-around or licensing plan |
Timing | Before filing | Before design freeze and before launch |
What a robust FTO should cover?
1. Precise product definition. Lock the features you will actually ship. Small feature changes can avoid a claim element entirely.
2. Comprehensive search and status checks. Use IP India’s Patent Search and E-Register for legal status and annuity data. Track pending divisional applications that may later grant with claim scope tailored to your segment.
3. Claim charting and legal analysis. Map each claim element to your product. If every element of an independent claim reads onto your product, risk is high. Consider doctrine-of-equivalents style reasoning prudently and examine prosecution histories where available.
4. Process patent caution. For process claims, Section 104A reverses the burden of proof in certain circumstances. If your product is identical to a product obtained by a patented process, the court can require you to prove you used a different process. FTO opinions should therefore probe process steps and supplier assurances carefully.
5. Regulatory exception is not a shield for sales. The Bayer decisions underline that Section 107A covers acts reasonably related to approvals. Commercial supply after approval needs FTO clearance.
6. Licensing and design-around strategies. If a claim is unavoidable, consider licensing. Otherwise, redesign to omit at least one essential element or to use a non-infringing alternative.
How to run an India focussed FTO effectively?
Define the geography. Start with India. If you plan multi-country launches, replicate the analysis for those jurisdictions separately.
Search broadly, filter smartly. Begin with IPC classes and key players in your space. Narrow to Indian grants in force and Indian national-phase entries that are close to grant.
Verify legal status. Use the E-Register to confirm whether a patent is active, expired, or ceased for non-payment, and calendar renewal dates that could revive risk.
Review claim trees. Focus on independent claims first. Dependent claims may still matter if they track your variant closely.
Assess design-around feasibility. Involve engineering early to evaluate cost and performance impact of alternatives.
Document a reasoned opinion. Summarise risk levels and assumptions. This becomes a living document for business, regulatory, and financing discussions.
Seeing FTO in connection with Indian jurisprudence
Claim-by-claim mapping. Roche v Cipla demonstrates that detailed claim analysis decides outcomes. An FTO chart that mirrors this discipline will be both decision-ready and litigation-resilient.
Strength of the patent versus public interest. In Merck v Glenmark, the court granted relief recognising the strength of Merck’s claim set, which signals that strong claims can halt competitors even mid-market. Your FTO must weigh not just infringement, but also validity defences you can credibly raise.
Interim relief standards. Bajaj Auto v TVS Motor reminds that interim injunctions depend on a robust prima facie case, balance of convenience, and irreparable harm. If your FTO flags a high-risk patent, a launch could trigger urgent injunctive motions, supply disruption, and inventory write-offs.
FAQ's
If I already have a patent, do I still need FTO?
Yes. A patent is a right to exclude others, not a positive right to practice. You could still infringe someone else’s earlier patent. FTO addresses that market-entry risk under Section 48.
Are expired patents a concern?
Expired Indian patents do not block launch. However, watch for pending divisionals from the same family that may still be prosecuted with claims tailored to your product category.
Do regulatory trials or bio-equivalence studies need FTO?
Activities reasonably related to regulatory submissions are sheltered by Section 107A as interpreted in Bayer v Union of India. Commercial manufacture and sales are not. Plan FTO for launch, and use the exception only for bona fide development.
How does FTO handle process claims when I buy from a third-party supplier?
Seek contractual representations and audit rights. Because Section 104A can shift the burden of proof, an FTO opinion should examine whether the supplier’s process could be identical to a patented process and whether alternative, documented processes exist.
Short takeaways
Treat FTO as a launch-gate, distinct from patentability.
Run India-specific searches and status checks on IP India’s Public Search and E-Register, then chart claims against your final product.
Use design-around or licensing early if a claim reads onto your product.
Remember that Section 107A covers only acts related to approvals, not commercial supply.
Be extra cautious with process patents given the Section 104A burden-shifting framework.
